Prostate Cancer
Home-based versus supervised group exercise in men with prostate cancer on androgen deprivation therapy: A randomized controlled trial and economic analysis.
November 21, 2023
A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population-The MiCheck-01 prospective trial.
November 21, 2023
Prostate Cancer Local Staging with Magnetic Resonance Imaging.
November 20, 2023
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC).
November 20, 2023
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging.
November 20, 2023
Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
November 17, 2023
Prostate Cancer, Race, and Health Disparity: What We Know.
November 17, 2023
A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients.
November 17, 2023
Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic Review.
November 17, 2023
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI.
November 16, 2023
Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial.
November 16, 2023